Chemotherapy-free Trastuzumab and Pertuzumab in HER2-positive Breast Cancer: FDG-PET Response-adapted Strategy.
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Perjeta|DRUG: Herceptin|DRUG: Docetaxel|DRUG: Carboplatin|DRUG: Letrozole|DRUG: Tamoxifen
Sponsor: MedSIR